(regulation 17)
Column 1 | Column 2 |
1 | goods prepared for the initial experimental studies in human volunteers |
2 | ingredients, except water, used in the manufacture of therapeutic goods where the ingredients: (a) do not have a therapeutic action; or (b) are herbs, bulk hamamelis water or oils extracted from herbs, the sole therapeutic use of which is as starting materials for use by a licensed manufacturer |
6 | dentifrices that contain no therapeutically active substance other than not more than 1000 milligrams per kilogram of fluoride |
7 | homoeopathic preparations more dilute than a one thousand fold dilution of a mother tincture and that are not required to be sterile |
8 | antiperspirant preparations that derive their antiperspirant properties from inorganic salts of aluminium, zinc or zirconium only |
9 | unmedicated anti - acne preparations having only a cleansing action or purpose |
10 | medicated insect repellents for dermal use, if the medication consists solely of an antiseptic having a secondary role in the formulation |
11 | lotions, shampoos or hairdressings for the prevention or treatment of dandruff |
11A | unmedicated preparations for topical use for protecting against, or providing relief from, nappy rash symptoms by acting only as a barrier for the skin (whether or not the preparations also have a moisturising action) |
12 | medicated soaps other than liquid medicated soaps |
13 | disinfectants |
15 | medicated throat lozenges, where the medication consists only of volatile oils and their constituents either alone or in combination with ascorbic acid or its salts |
16 | medicated space sprays where the medication consists only of volatile oils and their constituents |
17 | bulk, liquified medical gases |
18 | blood and blood components that are: (a) collected by a medical practitioner, registered under a law of a State or Territory, or a person under the professional supervision of such a practitioner, in the course of medical treatment and for the purposes of diagnosis of, and testing for, a medical condition; or (b) manufactured by a medical practitioner, registered under a law of a State or Territory, or a person under the professional supervision of such a practitioner, for therapeutic application to a patient under the practitioner's care; or (c) manufactured by a blood donation centre for a medical practitioner, registered under a law of a State or Territory, for therapeutic application to a particular patient under the practitioner's care |
19 | allergens for skin patch testing on unbroken skin |
20 | Medicinal oxygen cylinders that have been decant filled, transfilled or cascade filled by: (a) a hospital; or (b) an ambulance, fire or rescue service |
21 | Therapeutic goods in relation to which all of the following paragraphs apply: (a) the goods comprise, contain or are derived from human cells or human tissues collected from a patient who is under the clinical care of a medical or dental practitioner; (b) the goods are manufactured by, or under the professional supervision of, the practitioner; (c) the single indication of the goods is homologous use: (i) on that patient; and (ii) in a single clinical procedure; and (iii) by, or under the professional supervision of, that practitioner; (d) the goods have been subjected to only minimal manipulation; (e) the practitioner is registered in a State or internal Territory |
22 | radiopharmaceuticals that are: (a) manufactured by: (i) a medical practitioner registered under a law of a State or Territory when employed by a public or private hospital or a public institution, or a person under the professional supervision of such a medical practitioner; or (ii) a radiochemist when employed by a public or private hospital or a public institution, or a person under the professional supervision of such a radiochemist; or (iii) a pharmacist registered under a law of a State or Territory when employed by a public or private hospital or a public institution, or a person under the professional supervision of such a pharmacist; and (b) for supply to another public or private hospital, another public institution or a private institution within Australia for the purposes of: (i) diagnosing a medical condition in respect of a patient of the hospital or institution; or (ii) treating a medical condition of a patient of the hospital or institution |
23 | radiopharmaceutical active ingredients that are: (a) manufactured by: (i) a medical practitioner registered under a law of a State or Territory when employed by a public or private hospital or a public institution, or a person under the professional supervision of such a medical practitioner; or (ii) a radiochemist when employed by a public or private hospital or a public institution, or a person under the professional supervision of such a radiochemist; or (iii) a pharmacist registered under a law of a State or Territory when employed by a public or private hospital or a public institution, or a person under the professional supervision of such a pharmacist; and (b) for supply to another public or private hospital, another public institution or a private institution within Australia, which are then used by the hospital or institution to manufacture a radiopharmaceutical for the purposes of: (i) diagnosing a medical condition in respect of a patient of the hospital or institution; or (ii) treating a medical condition of a patient of the hospital or institution |